Literature DB >> 16390241

p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.

Emad Kaabipour1, Helen M Haupt, Jere B Stern, Peter A Kanetsky, Victoria F Podolski, Anne-Marie Martin.   

Abstract

CONTEXT: Distinguishing between keratoacanthoma (KA) and squamous cell carcinoma (SCC) is not an uncommon histologic diagnostic dilemma.
OBJECTIVE: To determine if p16 expression is useful in the differential diagnosis of SCC and KA.
DESIGN: We studied the expression of p16 by immunohistochemistry in 24 KAs, 24 infiltrating SCCs of the skin, 4 histologically indeterminate lesions, and 8 nonmalignant keratoses.
RESULTS: A range of immunohistochemical p16 expression was seen in KAs and SCCs in terms of the thickness of lesional staining and the percentage of cells staining. No significant difference in measures of p16 expression was identified among the KAs, the SCCs, the indeterminate lesions, or the benign keratoses.
CONCLUSIONS: These findings suggest that p16 is not a useful marker to distinguish between KA and SCC, supporting the similarity between the 2 lesions; p16 alterations appear to play a role in the pathogenesis of both KA and SCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16390241     DOI: 10.5858/2006-130-69-PEIKAS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  The Role of p16, p21, p27, p53 and Ki-67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study.

Authors:  Recep Bedir; Hasan Güçer; İbrahim Şehitoğlu; Cüneyt Yurdakul; Pelin Bağcı; Pelin Üstüner
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

2.  Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence.

Authors:  Po Zhao; Xin Mao; Ian C Talbot
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

3.  IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.

Authors:  S Soddu; E Di Felice; S Cabras; M E Castellanos; L Atzori; G Faa; L Pilloni
Journal:  Eur J Histochem       Date:  2013-02-14       Impact factor: 3.188

4.  Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.

Authors:  Isabela C Watanabe; Renata F Magalhães; Aparecida M de Moraes; Rafael F Stelini; Geórgia F Cintra; Konradin Metze; Maria L Cintra
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

5.  Clinical, histopathological and immunohistochemical study of keratoacanthoma.

Authors:  Alina Maria Vîlcea; Loredana Elena Stoica; Claudia Valentina Georgescu; Florina Carmen Popescu; Raluca Niculina Ciurea; Ionică Daniel Vîlcea; Cecil Sorin Mirea
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

6.  Keratoacanthoma of the Lip: Activation of the mTOR Pathway, Tumor Suppressor Proteins, and Tumor Senescence.

Authors:  Caroline Siviero Dillenburg; Manoela Domingues Martins; Luise Meurer; Rogerio Moraes Castilho; Cristiane Helena Squarize
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.